ARCHIVES

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: George Burton Retires After 23 Years At NCI; MDA Names Bodey Head Of Medical Specialists

February 20, 1987

Rauscher Explains Reasons for Treatment Switches

May 9, 1975

Synar Bill Provides FDA Regulation Of Tobacco Products

March 4, 1994

AACR Presents Awards at Annual Meeting

April 5, 2013

NCI Communications Office to contract Media Campaigns

October 22, 1993

In Brief: HHS Drags Feet, NCI Considering Contract To Review Cancer Research Facility Needs

October 14, 1983